Microbial strain engineering for the production of structurally defined carbohydrates with immunomodulating properties

Synthetic Biology and Metabolic Engineering for microbial COS production

Understanding bacterial stress: Systems metabolic engineering to unlock the potential of <i>Escherichia coli</i> for amino sugar derivative production.

Accelerated adaptive laboratory evolution for conversion of probiotic hosts towards sustainable and resilient cell factories for high-value applications: Microbial synthesis of defined chitinpentaose as proof-of-concept

Advanced Licensable Pathway for Hyaluronan and Amino sugar bioproduction

Completing the product-market fit of the B-COS platform: biological plant priming for a customized agriculture

COS4AnimalHealth - Chitooligosaccharides platform for animal health applications

Identifying all players in the cell: A pipeline to unlock microbial production of 3rd generation defined chitooligosaccharides.

Merging immunology with synthetic biology to improve animal health: strain engineering for the production of structurally defined carbohydrates with immunomodulating properties

MyCOS - Synthetic biology for a sustainable conversion of fungal chitin-rich waste streams into valuable biobased chitooligosaccharides for plant health

Development of microbial cell factories for the production of chitoheptaose and -octaose using metabolic and protein engineering: Promising molecules with an underexplored potential for plant, animal and human health